A citation-based method for searching scientific literature

Emma Ahlqvist, Petter Storm, Annemari Käräjämäki, Mats Martinell, Mozhgan Dorkhan, Annelie Carlsson, Petter Vikman, Rashmi B Prasad, Dina Mansour Aly, Peter Almgren, Ylva Wessman, Nael Shaat, Peter Spégel, Hindrik Mulder, Eero Lindholm, Olle Melander, Ola Hansson, Ulf Malmqvist, Åke Lernmark, Kaj Lahti, Tom Forsén, Tiinamaija Tuomi, Anders H Rosengren, Leif Groop. Lancet Diabetes Endocrinol 2018
Times Cited: 567







List of co-cited articles
414 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study.
Oana P Zaharia, Klaus Strassburger, Alexander Strom, Gidon J Bönhof, Yanislava Karusheva, Sofia Antoniou, Kálmán Bódis, Daniel F Markgraf, Volker Burkart, Karsten Müssig,[...]. Lancet Diabetes Endocrinol 2019
96
18


Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: A soft clustering analysis.
Miriam S Udler, Jaegil Kim, Marcin von Grotthuss, Sílvia Bonàs-Guarch, Joanne B Cole, Joshua Chiou, Michael Boehnke, Markku Laakso, Gil Atzmon, Benjamin Glaser,[...]. PLoS Med 2018
126
15

The many faces of diabetes: a disease with increasing heterogeneity.
Tiinamaija Tuomi, Nicola Santoro, Sonia Caprio, Mengyin Cai, Jianping Weng, Leif Groop. Lancet 2014
302
8

10-year follow-up of intensive glucose control in type 2 diabetes.
Rury R Holman, Sanjoy K Paul, M Angelyn Bethel, David R Matthews, H Andrew W Neil. N Engl J Med 2008
8


Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps.
Anubha Mahajan, Daniel Taliun, Matthias Thurner, Neil R Robertson, Jason M Torres, N William Rayner, Anthony J Payne, Valgerdur Steinthorsdottir, Robert A Scott, Niels Grarup,[...]. Nat Genet 2018
445
6

2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
John B Buse, Deborah J Wexler, Apostolos Tsapas, Peter Rossing, Geltrude Mingrone, Chantal Mathieu, David A D'Alessio, Melanie J Davies. Diabetes Care 2020
329
6

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
6

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
6


Effects of intensive glucose lowering in type 2 diabetes.
Hertzel C Gerstein, Michael E Miller, Robert P Byington, David C Goff, J Thomas Bigger, John B Buse, William C Cushman, Saul Genuth, Faramarz Ismail-Beigi, Richard H Grimm,[...]. N Engl J Med 2008
6


Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes.
Stephen D Wiviott, Itamar Raz, Marc P Bonaca, Ofri Mosenzon, Eri T Kato, Avivit Cahn, Michael G Silverman, Thomas A Zelniker, Julia F Kuder, Sabina A Murphy,[...]. N Engl J Med 2019
5

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Vlado Perkovic, Meg J Jardine, Bruce Neal, Severine Bompoint, Hiddo J L Heerspink, David M Charytan, Robert Edwards, Rajiv Agarwal, George Bakris, Scott Bull,[...]. N Engl J Med 2019
5

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.
Bernard Zinman, Christoph Wanner, John M Lachin, David Fitchett, Erich Bluhmki, Stefan Hantel, Michaela Mattheus, Theresa Devins, Odd Erik Johansen, Hans J Woerle,[...]. N Engl J Med 2015
5

Novel subgroups of patients with adult-onset diabetes in Chinese and US populations.
Xiantong Zou, Xianghai Zhou, Zhanxing Zhu, Linong Ji. Lancet Diabetes Endocrinol 2019
37
13



Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes.
Robert Wagner, Martin Heni, Adam G Tabák, Jürgen Machann, Fritz Schick, Elko Randrianarisoa, Martin Hrabě de Angelis, Andreas L Birkenfeld, Norbert Stefan, Andreas Peter,[...]. Nat Med 2021
24
20

GADA titer-related risk for organ-specific autoimmunity in LADA subjects subdivided according to gender (NIRAD study 6).
Simona Zampetti, Marco Capizzi, Marialuisa Spoletini, Giuseppe Campagna, Gaetano Leto, Laura Cipolloni, Claudio Tiberti, Emanuele Bosi, Alberto Falorni, Raffaella Buzzetti. J Clin Endocrinol Metab 2012
49
8

Pathophysiology-based phenotyping in type 2 diabetes: A clinical classification tool.
Jacob V Stidsen, Jan E Henriksen, Michael H Olsen, Reimar W Thomsen, Jens S Nielsen, Jørgen Rungby, Sinna P Ulrichsen, Klara Berencsi, Johnny A Kahlert, Søren G Friborg,[...]. Diabetes Metab Res Rev 2018
13
30

Use and abuse of HOMA modeling.
Tara M Wallace, Jonathan C Levy, David R Matthews. Diabetes Care 2004
4

Precision diabetes: learning from monogenic diabetes.
Andrew T Hattersley, Kashyap A Patel. Diabetologia 2017
114
4

Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.
Steven P Marso, Stephen C Bain, Agostino Consoli, Freddy G Eliaschewitz, Esteban Jódar, Lawrence A Leiter, Ildiko Lingvay, Julio Rosenstock, Jochen Seufert, Mark L Warren,[...]. N Engl J Med 2016
4

Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial.
Hertzel C Gerstein, Helen M Colhoun, Gilles R Dagenais, Rafael Diaz, Mark Lakshmanan, Prem Pais, Jeffrey Probstfield, Jeffrey S Riesmeyer, Matthew C Riddle, Lars Rydén,[...]. Lancet 2019
656
4

Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).
Melanie J Davies, David A D'Alessio, Judith Fradkin, Walter N Kernan, Chantal Mathieu, Geltrude Mingrone, Peter Rossing, Apostolos Tsapas, Deborah J Wexler, John B Buse. Diabetologia 2018
514
4


Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study.
I M Stratton, A I Adler, H A Neil, D R Matthews, S E Manley, C A Cull, D Hadden, R C Turner, R R Holman. BMJ 2000
4

Effects of dapagliflozin and n-3 carboxylic acids on non-alcoholic fatty liver disease in people with type 2 diabetes: a double-blind randomised placebo-controlled study.
Jan W Eriksson, Per Lundkvist, Per-Anders Jansson, Lars Johansson, Mats Kvarnström, Linda Moris, Tasso Miliotis, Gun-Britt Forsberg, Ulf Risérus, Lars Lind,[...]. Diabetologia 2018
125
4

Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study.
Ranjit Mohan Anjana, Viswanathan Baskar, Anand Thakarakkattil Narayanan Nair, Saravanan Jebarani, Moneeza Kalhan Siddiqui, Rajendra Pradeepa, Ranjit Unnikrishnan, Colin Palmer, Ewan Pearson, Viswanathan Mohan. BMJ Open Diabetes Res Care 2020
16
25

Identification of type 2 diabetes subgroups through topological analysis of patient similarity.
Li Li, Wei-Yi Cheng, Benjamin S Glicksberg, Omri Gottesman, Ronald Tamler, Rong Chen, Erwin P Bottinger, Joel T Dudley. Sci Transl Med 2015
199
4

Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition.
Pouya Saeedi, Inga Petersohn, Paraskevi Salpea, Belma Malanda, Suvi Karuranga, Nigel Unwin, Stephen Colagiuri, Leonor Guariguata, Ayesha A Motala, Katherine Ogurtsova,[...]. Diabetes Res Clin Pract 2019
4

Incidence of complications in young-onset diabetes: Comparing type 2 with type 1 (the young diab study).
Anandakumar Amutha, Ranjit Mohan Anjana, Ulagamathesan Venkatesan, Harish Ranjani, Ranjit Unnikrishnan, K M V Narayan, Viswanathan Mohan, Mohammed K Ali. Diabetes Res Clin Pract 2017
32
9

Higher incidence of diabetic nephropathy in type 2 than in type 1 diabetes in early-onset diabetes in Japan.
H Yokoyama, M Okudaira, T Otani, A Sato, J Miura, H Takaike, H Yamada, K Muto, Y Uchigata, Y Ohashi,[...]. Kidney Int 2000
127
3

Latent Autoimmune Diabetes in Adults in the United Arab Emirates: Clinical Features and Factors Related to Insulin-Requirement.
Ernesto Maddaloni, Nader Lessan, Alia Al Tikriti, Raffaella Buzzetti, Paolo Pozzilli, Maha T Barakat. PLoS One 2015
42
7

Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.
T Tuomi, A Carlsson, H Li, B Isomaa, A Miettinen, A Nilsson, M Nissén, B O Ehrnström, B Forsén, B Snickars,[...]. Diabetes 1999
359
3

First Genome-Wide Association Study of Latent Autoimmune Diabetes in Adults Reveals Novel Insights Linking Immune and Metabolic Diabetes.
Diana L Cousminer, Emma Ahlqvist, Rajashree Mishra, Mette K Andersen, Alessandra Chesi, Mohammad I Hawa, Asa Davis, Kenyaita M Hodge, Jonathan P Bradfield, Kaixin Zhou,[...]. Diabetes Care 2018
51
5

Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe.
Bernard Zinman, Steven E Kahn, Steven M Haffner, M Colleen O'Neill, Mark A Heise, Martin I Freed. Diabetes 2004
113
3


Interaction Between Overweight and Genotypes of HLA, TCF7L2, and FTO in Relation to the Risk of Latent Autoimmune Diabetes in Adults and Type 2 Diabetes.
Rebecka Hjort, Josefin E Löfvenborg, Emma Ahlqvist, Lars Alfredsson, Tomas Andersson, Valdemar Grill, Leif Groop, Elin P Sørgjerd, Tiinamaija Tuomi, Bjørn Olav Åsvold,[...]. J Clin Endocrinol Metab 2019
16
18

Markers of β-Cell Failure Predict Poor Glycemic Response to GLP-1 Receptor Agonist Therapy in Type 2 Diabetes.
Angus G Jones, Timothy J McDonald, Beverley M Shields, Anita V Hill, Christopher J Hyde, Bridget A Knight, Andrew T Hattersley. Diabetes Care 2016
73
4

Latent autoimmune diabetes in adults (LADA) should be less latent.
S Fourlanos, F Dotta, C J Greenbaum, J P Palmer, O Rolandsson, P G Colman, L C Harrison. Diabetologia 2005
202
3


High titer of autoantibodies to GAD identifies a specific phenotype of adult-onset autoimmune diabetes.
Raffaella Buzzetti, Sergio Di Pietro, Andrea Giaccari, Antonio Petrone, Mattia Locatelli, Concetta Suraci, Marco Capizzi, Maria Luisa Arpi, Elena Bazzigaluppi, Francesco Dotta,[...]. Diabetes Care 2007
140
3

Adult-onset autoimmune diabetes: current knowledge and implications for management.
Raffaella Buzzetti, Simona Zampetti, Ernesto Maddaloni. Nat Rev Endocrinol 2017
82
3

Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study.
Zhiguang Zhou, Yufei Xiang, Linong Ji, Weiping Jia, Guang Ning, Gan Huang, Lin Yang, Jian Lin, Zhenqi Liu, William A Hagopian,[...]. Diabetes 2013
138
3



Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management.
Naveed Sattar, Jason M R Gill. Lancet Diabetes Endocrinol 2015
102
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.